Africa: Advances in PrEP Options and HIV Vaccine Research Unveiled at HIVR4P 2024, the 5th HIV Research for Prevention Conference

[HIVR4P2024] Lima, Peru — New data from the PURPOSE 2 study of twice-yearly lenacapavir for HIV prevention are among the scientific highlights at HIVR4P 2024, the 5th HIV Research for Prevention Conference, taking place in Lima, Peru, and virtually from 6 to 10 October.



Source link : https://allafrica.com/stories/202410070546.html

Author :

Publish date : 2024-10-07 15:03:03

Copyright for syndicated content belongs to the linked Source.